Bhavna Joshi
Scientific Tracks Abstracts: Anaplastology
It is needless to say that cancer is a hazardous disease to mankind. The universal statistics points towards the same thing. It is necessity of the day to re-evaluate the ayurvedic claims against the cancer & to re-examine them, as present modern science wants & to give opinion on the justification of the ayurvedic claims. This is the evaluatory purpose of this present study the main property of aswagandha is a natural anti-oxidant, which helps to increase the molecular effect of radiation. Thus this drug acted both directly on cancer cells and by making them more sensitive to radiotherapy. Aswagandha helps to decrease the amount of glutathione in tumor cells after which radiation therapy become more effective. The overall objective of this study is to compare the efficacy of radiotherapy plus herbal therapy in previously untreated oral cavity and cervical cancer. Important efficacy endpoints will be objective tumor response rate, duration of response, proportion of patient with early progressive disease or early response-stable disease. . The main objective of this season is highlighting the cancer in ayurveda, its diagnosis, treatment, research and prevention.
Bhavna Joshi (M.D.Ayu.Onco.Gold Medalist, Gujarat Ayurved University), Consultant Cancer Physician and Director- Atharva Multispeciality Ayurveda Hospital, Cancer Research Center, Rajkot, President-International Cancer Foundation. She has published more than 10 papers in national and international conferences on Oncology research i.e. ASCO-PAN Asia Conference at New Delhi in Feb-2002. Poster presentation at GCRI- Ahmedabad in AROI national conference. International conference on cancer at NCI- National Cancer Institute, Betehesda, USA. Dec. 2007.
